West Virginia Oncology Society
ASCO issued its latest recommendations for genetic testing for cancer susceptibility. The updated
statement addresses new developments during the past seven years, including the availability of
genetic tests of unproven clinical benefit and direct-to-consumer (DTC) genetic testing.
Read the
press release, visit Cancer.Net for information for your patients, and read the statement in JCO.
ASCO Releases Updated Policy Statement on Genetic Testing
American Society of Clinical Oncology (ASCO)